Information Provided By:
Fly News Breaks for December 31, 2019
Dec 31, 2019 | 08:51 EDT
Cowen analyst Marc Bianchi lowered his price target on Core Laboratories to $39 and kept his Market Perform rating after its below-consensus Q4 pre-announcement and a 50% dividend cut. The analyst cites the "20% sequential completions decline" in the U.S. disclosed by the company along with the slower than anticipated progress for large international and offshore projects. Bianchi adds that Core Laboratories' Q1's international R&D should benefit from committed projects that were pushed from Q4, but he believes that the improvement is likely to be more gradual than assumed by the management.
News For CLB From the Last 2 Days
There are no results for your query CLB